XXD-58308-80474
4 vaccinations
11 coded responses
54 check-ins
10 free-text entries
5 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 532 / WI
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Moderna
- 2021-03-18
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
-
2021-04-16
Dose 2 — Moderna
- 2021-04-18
-
2021-04-19
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal — Feeling: Fair · Site: Pain · Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Palpitations — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-21
Survey response — days 1–6 daily, dose 2MedDRA: Arrhythmia, Atrial tachycardia — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-21
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-22
Survey response — days 1–6 daily, dose 2MedDRA: Atrial tachycardia, Tachycardia — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-22
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-24
Health check-in — 7 day, dose 2Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-04-30
- 2021-05-08
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-07-16
- 2021-10-15
-
2021-11-15
Dose 3 — ModernaCo-administered: Tetanus
- 2021-11-15
-
2021-11-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-17
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessMedDRA releases: 2024-11 · check-in answers available
-
2021-11-18
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-11-19
- 2021-11-20
-
2021-11-21
Survey response — days 1–6 daily, dose 3MedDRA: Nasopharyngitis — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2021-11-22
Health check-in — 7 day, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-29
Survey response — 14 day, dose 3MedDRA: Bronchitis viral, Telemedicine — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11 · check-in answers available
-
2021-11-29
Report sent to call center — 14 day, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-30
Call successfulCompleted over the phone
-
2021-11-30
Call successfulCompleted over the phone
-
2021-11-30
Call successfulCompleted over the phone
- 2021-12-06
- 2021-12-13
- 2021-12-20
-
2021-12-27
Survey response — 42 day, dose 3MedDRA: Diarrhoea, Fatigue, Headache, Sinus congestion — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11 · check-in answers available
-
2021-12-27
Report sent to call center — 42 day, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-28
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2022-02-14
- 2022-05-16
-
2022-11-04
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-04
-
2022-11-05
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-11-06
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-11-07
- 2022-11-08
-
2022-11-09
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-11-10
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-11-11
Health check-in — 7 day, dose 4Feeling: Fair · Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-11-18
Survey response — 14 day, dose 4MedDRA: Dyspnoea, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2022-11-25
- 2022-12-02
-
2022-12-09
Survey response — 35 day, dose 4MedDRA: Ageusia, Cough, Diarrhoea, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative, Sinus congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2022-12-16
-
2023-02-03
Survey response — 3 month, dose 4MedDRA: Nephrolithiasis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitMedDRA releases: 2024-11 · check-in answers available
-
2023-02-03
Report sent to call center — 3 month, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2023-02-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-05-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Moderna | |
| 2 | 2021-04-16 | Moderna | |
| 3 | 2021-11-15 | Moderna | Tetanus |
| 4 | 2022-11-04 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-21 | Successful 2021-11-30 |
Completed over the phone |
| 2021-04-22 | Successful 2021-11-30 |
Completed over the phone |
| 2021-11-29 | Successful 2021-11-30 |
Completed over the phone |
| 2021-12-27 | Successful 2021-12-28 |
Reported to VAERS voluntarily prior to GDIT contact |
| 2023-02-03 | Successful 2023-02-06 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 7
Systemic reaction (other): Mental fogginess (difficulty remembering & focusing)
Systemic reaction (other): Sore throat, heart palpitations
Systemic reaction (other): Heart arrhythmia (atrial tachycardia)
Systemic reaction (other): Atrial tachycardia
Healthcare visit (other): Outpatient procedure to correct tachycardia
Release 10
Systemic reaction (other): Sore throat
Systemic reaction (other): Suspecting common cold. Unlikely my booster had anything to do with this.
Symptoms: Suspected case of viral bronchitis (via e-visit with dr)
Symptoms: Sinus congestion, diarrhea, headache, fatigue
Release 12
Symptoms: Increased fatigue and shortness of breath.
Symptoms: Chest congestion, diarrhea, loss of taste, sinus congestion, cough, fever. Consist negative COVID test result (home test every 2 days).
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Tachycardia | ✓ | ✓ | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Bronchitis viral | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nephrolithiasis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Telemedicine | · | · | ✓ |
| SRO | Arrhythmia | ✓ | ✓ | ✓ |
| SRO | Atrial tachycardia | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release